Horizon has been ranked as one of the fastest growing biotechnology companies in Europe by Deloitte with a staff of more than 80 people spread across scientific, operations and commercial functions and accommodated within a 17,800 sq. ft. state-of-art facility in Cambridge, UK. The company has grown rapidly and now has a customer base comprising almost 800 organisations including major pharmaceutical, biotech and diagnostic companies as well as leading academic research centres. Horizon was named the 2012 East of England Business of the Year and the company’s success in supplying its products and services in overseas markets led to the company receiving the 2012 Queen’s Award for Enterprise in International Trade.
Horizon was founded in 2005 by Dr Chris Torrance and Professor Alberto Bardelli and builds upon a 20 year heritage in oncology research, translational medicine and genome-editing.